Tenax Therapeutics (TENX) Posts Q2 Loss of 14c/Share

Tenax Therapeutics (NASDAQ: TENX) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS